Techops Controller

2 semanas atrás


Lisboa, Lisboa, Portugal Ferring International Center S.A. Tempo inteiro

In 2023, we committed to net-zero by 2050, were recognised in Fortune's Change the World list and awarded the Gallup Exceptional Workplace Award.

Learn more BEYOND trial results demonstrate efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol Learn more Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth Learn more Please install the oAuth Twitter Feed Plugin and follow the theme documentation to set it up.

Please install the oAuth Twitter Feed Plugin and follow the theme documentation to set it up.

Helping mothers and babies, from conception to birth At Ferring, we are committed to helping people become parents and to keeping mothers and babies healthy, from conception to birth.

Over one third of our research and development investment goes towards finding innovative treatments in reproductive medicine and maternal health.

We are also passionate about making a difference to people's health and quality of life through our work in gastroenterology and urology.

Each of us at Ferring contribute to providing innovative solutions to help people live better lives. We devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.

At Ferring Pharmaceuticals we highly value an attractive working environment that motivates our employees and stimulates the creative abilities and initiative of both individuals and teams.

With more than 7,000 employees in over 50 countries, we are able to draw upon a large multicultural setting to enrich the work of our staff on all levels.

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.

Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.

BEYOND is the first randomised controlled trial comparing efficacy and safety of follitropin delta (Rekovelle) in a gonadotrophin-releasing hormone (GnRH) agonist versus antagonist protocol during first ovarian...

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring's U.S.

approved Adstiladrin (nadofaragene firadenovec-vncg) The deal assures diversity of supply to meet future long-term plans for expanded availability of the gene therapy...

Ferring reported annual revenues of €2.2 billion, an increase of +1% at constant exchange rates, supported by robust sales performance in core franchise and legacy products Launches of Rebyota and Adstiladrin in...

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.
This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.
I confirm that I am a healthcare professional or have a business relationship with Ferring Pharmaceuticals OK
Please wait while you are redirected to the right page...
#J-18808-Ljbffr
  • Techops Controller

    2 semanas atrás


    Lisboa, Lisboa, Portugal Ferring Pharmaceuticals, Inc. Tempo inteiro

    Job Description:At Ferring Pharmaceuticals, we help people around the world build families and live better lifes. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women's health, gastroenterology and urology. Ferring + You is all about working together and sharing ideas, so that we can...

  • TechOps Controller

    2 semanas atrás


    Lisboa, Lisboa, Portugal Ferring Pharmaceuticals Tempo inteiro

    Job Description:At Ferring Pharmaceuticals, we help people around the world build families and live better lifes. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women's health, gastroenterology and urology. Ferring + You is all about working together and sharing ideas, so that we can...

  • Techops Consolidation

    2 semanas atrás


    Lisboa, Lisboa, Portugal Ferring Pharmaceuticals, Inc. Tempo inteiro

    Job Description:TechOps Consolidation & Reporting ManagerAt Ferring Pharmaceuticals, we help people around the world build families and live better lifes. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women's health, gastroenterology and urology. Ferring + You is all about working...

  • Techops Controller

    Há 7 dias


    Lisboa, Portugal Ferring Pharmaceuticals, Inc. Tempo inteiro

    Job Description: At Ferring Pharmaceuticals, we help people around the world build families and live better lifes. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women’s health, gastroenterology and urology. Ferring + You is all about working together and sharing ideas, so that we...

  • Techops Consolidation

    4 semanas atrás


    Lisboa, Portugal Ferring Pharmaceuticals, Inc. Tempo inteiro

    Job Description: TechOps Consolidation & Reporting Manager At Ferring Pharmaceuticals, we help people around the world build families and live better lifes. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women’s health, gastroenterology and urology. Ferring + You is all about...

  • Techops Controller

    4 semanas atrás


    Lisboa, Portugal Ferring International Center S.A. Tempo inteiro

    In 2023, we committed to net-zero by 2050, were recognised in Fortune's Change the World list and awarded the Gallup Exceptional Workplace Award. Learn more BEYOND trial results demonstrate efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol Learn more Launch of two first-in-class medicines in 2023...